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Cyclicvomitingsyndrome(CVS)sharesmanyfeatureswithmigraineheadache,includingauras,photophobia,andantimigrainous
treatment response being traditionally viewed as a migraine variant. Aims. To determine whether CVS is associated with the same
disordersasmigraineheadache,andcomparetheseassociationstothoseinhealthycontrolsubjects.Methods.Cross-sectionalstudy
of patients utilizing the ODYSA instrument, evaluating the probability of 12 functional/autonomic diagnoses, CVS, migraine,
orthostatic intolerance (OI), reﬂex syncope, interstitial cystitis, Raynaud’s syndrome, complex regional pain syndrome (CRPS),
irritable bowel syndrome, functional dyspepsia, functional abdominal pain, ﬁbromyalgia, and chronic fatigue syndrome. Control
subjects were age-matched gender-matched friends. Patients had to fulﬁll criteria for CVS or migraine, while control subjects
could not. Results. 103 subjects were studied, 21 with CVS, 46 with migraine and 36 healthy controls. CVS and migraine did not
diﬀer in the relative frequencies of ﬁbromyalgia, OI, syncope, and functional dyspepsia. However, CVS patients did demonstrate a
signiﬁcantly elevated frequency of CRPS. Conclusions. Although CVS and migraine clearly share many of the same comorbidities,
they do diﬀer in one important association, suggesting that they may not be identical in pathophysiology. Since OI is common in
CVS, treatment strategies could also target this abnormality.
Copyright © 2009 Gisela Chelimsky et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Cyclicvomitingsyndrome(CVS)isaconditioncharacterized
by stereotypical episodes of severe nausea and vomiting
that last for several hours to several days, with return to
baseline health between episodes [1]. CVS aﬀects up to
2% of the population, and is described more commonly
in children than in adults [2]. The episodes of vomiting
vary in intensity and duration and are associated with
pallor, increased salivation, listlessness, anorexia, nausea,
retching,abdominalpain,headache,andphotophobia.Many
of these symptoms are thought to be generated by the
autonomic nervous system and they are also present in
patients with migraine [3]. CVS has no known etiology but
arelationshiptomigraineispostulatedbaseduponanecdotal
similarities such as antecedent auras, associated headaches,
andphotophobia[4].Inaddition,CVSisthoughttorespond
reasonably to migraine therapy and one third of cases will
evolve into migraines [5]. Furthermore, nausea or vomiting
constitutesenoughofacornerstoneofmigrainepresentation
to be part of the criteria given by the International Headache
Society [6]. Abdominal pain may also accompany migraine
[7] but its clinical signiﬁcance is unclear. Collectively,
these symptoms may reﬂect involvement of the autonomic
nervous system in migraine and CVS and hence suggest a
common pathogenesis.
Migraine bears several well-described associations with
other disorders such as ﬁbromyalgia [8], irritable bowel2 Gastroenterology Research and Practice
syndrome [9], and syncope [10]. In this study, we show
the spectrum of clinical similarities between subjects with
migraine and CVS in comparison to control subjects.
2. Methods
This is a cross-sectional IRB approved review of the Ohio
Dysautonomia (ODYSA) questionnaire. We enrolled sub-
jects who fulﬁlled the criteria for CVS, migraine, and healthy
control subjects.
Instrument. The ODYSA survey is a thorough clinical
questionnaire designed to gather diagnostic information
about 12 diﬀerent autonomic disorders, which includes
orthostatic intolerance, reﬂex syncope, CVS, interstitial cys-
titis, Raynaud’s syndrome, complex regional pain syndrome
(CRPS), irritable bowel syndrome, functional dyspepsia,
functional abdominal pain, migraine headache, ﬁbromyal-
gia, and chronic fatigue syndrome. The ODYSA question-
naire was developed to explore the extent to which these
disordersareinterrelated.TheODYSAinstrumentwasdevel-
oped over the last 6 years by a group of specialists including
2 urologists, 2 cardiologists, 2 neurologists, 1 adult gastroen-
terologist, 2 pediatric gastroenterologists, 1 rheumatologist,
2 geneticists, 1 epidemiologist, 1 psychologist, and 2 basic
scientists with a particular interest in the dysautonomias
within their ﬁeld of expertise. We aimed to design and val-
idate a clinical instrument able to noninvasively approximate
the diagnosis of each of 12 dysautonomias. Where validated
or published question-based diagnostic tools were available,
we utilized these directly or modiﬁed them, as detailed below
in Table 1, for each of the 12 disorders in the following table
to create the ODYSA questionnaire. Although the resulting
instrument is 19 pages long, it takes an average of only
16 minutes to complete, because we designed it to allow
subjectstoskipentirepagesbasedontheleadquestiononthe
page, which ascertains whether any relevant symptoms are
present.
3. Instrument
In the ODYSA questionnaire, a set of “probability” questions
and a set of “severity” questions are embedded within the
question set for each of the 12 disorders. The probability set
is utilized to determine whether or not the responder has the
disorder, while the severity set determines how disabling the
disorder is to the subject. Only the probability set is assessed
for evaluation of whether or not to include the subject in the
groupwiththedisorder.Probabilityscoringisforcedto0or1
(nointermediatevalues),whiletheseverityscorerangesfrom
0 to 10. These scores are programmed into a Filemaker Pro
database to be generated automatically as each subject’s data
are entered. No observer input is required. Probability score
determinations for comorbid disorders are listed below. The
probability scores for CVS and migraine headache are listed
under subject inclusions.
(1) Orthostatic Intolerance. The orthostatic intolerance
probability criteria were validated against a tilt-table study
demonstrating a positive and negative predictive values
of 90.4% and 94.1% (unpublished data, manuscript in
preparation).
(2) Interstitial Cystitis. We utilized 2 methods. (1)
O’Leary-Sant Method. The validated and published O’Leary-
Sant probability question set [21] addresses urinary urgency
and frequency, nocturia, and pain or burning in the
bladder. Scoring is performed by the program according
to the original publication. (2) NIDDK Method. Additional
questions were added following the NIDDK conference of
2006 to better assess the key diagnostic historical criteria
of PBS such as pain that worsens with ﬁlling and that
improves with voiding. These questions are face-valid as
agreed in a teleconference with several experts in the ﬁeld.
Preliminary review of data suggested better reliability and
validity of scoring method 2, which is the one currently
in use.
(3) Fibromyalgia probability depends on the duration
and location of pain that the subject experiences. The subject
must experience pain for longer than 3 months, in question
F2. Also, the subject has to assign a value to the pain ranging
from 0 (no pain) to 5 (intolerable pain) in 21 speciﬁc areas
of the body. These 21 points are divided into 4 quadrants:
right upper, right lower, left upper, and left lower. Pain must
b ep r e s e n ti na tl e a s to n es i t ei ne a c ho ft h ef o u rq u a d r a n t s
of the body for the subject to have a probability of 1. Finally,
the total score of the values assigned to each point must be
greater than 4, meaning each quadrant has at least 1 area of
tenderness. This set is face-valid. We also include a McGill
Short Form [17], not utilized in this data set.
(4) Reﬂex Syncope. The probability of syncope relies on
frequency and duration of loss of consciousness. Most of
these questions were validated and published by Sheldon
(2002, 2006) [15, 16] .F o rs u b j e c t st os c o r eas y n c o p e
probabilityof1,theymustbeconsciousnessmostofthetime;
unconsciousness must last less than 5 minutes, and it should
take less than 1 hour until the subject returns to baseline
awareness.
(5) Irritable Bowel Syndrome is based entirely on inclu-
sion criteria and modular questions published in the Rome
II book [11]. A subject must have experienced pain or
discomfort in the center of the abdomen for at least
3 months, their discomfort or pain must improve after
having a bowel movement, and the number and quality of
bowel movements must change with the onset of pain or
discomfort.
(6) Functional Dyspepsia is also based entirely on Rome
II published criteria and modular questions [11]. Pain or
discomfort must be centered in the upper abdomen with
no evidence of an organic disease as likely cause, and no
evidencethatpainisrelievedbydefecationorassociatedwith
the onset of a change in stool frequency or form (which
would qualify for IBS).
4.Subjects
Subjects were recruited from the autonomic laboratory,
adult and pediatric clinics of diﬀerent services including
gastrointestinal, rheumatology, urology, autonomic, general
neurology, and family medicine specialties at 3 tertiary careGastroenterology Research and Practice 3
Table 1: Inclusion Criteria. This table shows the source of the adapted inclusion criteria for the comorbidities mentioned in ODYSA
questionnaire.
Type of disease Disease Source
Bowel and bladder
Irritable bowel syndrome Rome II criteria, 2nd. Ed., 2000 [11]
Interstitial Cystitis O’Leary-Sant Questions Urology, 1997, [12]
Unmodiﬁed
Cyclic vomiting syndrome JPGN, 2008 [13]
Functional Dyspepsia Rome II criteria, 2nd. Ed., 2000 [11]
Functional Abdominal Pain Rome II criteria, 2nd. Ed., 2000 [11]
Cardiology Orthostatic intolerance
Developed and partially validated by
investigators, based on diagnostic criteria in
Clinical Autonomic Disorders PA Low, 1997 [14]
Reﬂex Syncope Based on Question sets validated by Sheldon
JACC, 2002; Eur Heart J, 2006 [15, 16]
Pain and fatigue
Migraine Headache
Face-valid questions developed by the
investigators based on IHS Classiﬁcation,
Cephalalgia, 2004 [6]
Fibromyalgia Pain Score Localizer from JM Olson, 2001 McGill
Short Form Questionnaire [17]
Complex Regional Pain
Syndrome/Reﬂex
Sympathetic Dystrophy
Face-valid questions developed by the
investigators based on IASP Criteria and
Chelimsky, 1995 [18, 19]
Chronic Fatigue Syndrome Face-valid questions developed by the
investigators based on CDC Criteria [20]
Raynaud’s syndrome Face-valid questions developed by the
investigators
centers in Northeast Ohio. Each subject was asked to solicit
their spouse or a friend to complete the survey as a control.
The inclusion criteria of CVS were adapted from The
North American Society for Pediatric Gastroenterology,
Hepatology and Nutrition clinical guidelines on the diagno-
sis and management of CVS [13]. These criteria included
at least 3 episodes of intense vomiting and nausea in 6
months period or a total of 5 attacks in a lifetime. These
episodes had to last from 1 hour to 10 days with a peak
vomiting frequency of at least 4 emeses per hour and had to
occur at least 1 week apart with a return to baseline health
between episodes. Knowing that CVS may have a milder
presentation, we also included a less severe patient group
(“milder CVS”) who met all of the other criteria except that
the peak vomiting frequency could be from 1–3 episodes per
hour. The inclusion criteria for migraine were adapted from
the International Headache Society [6] and these included
5 or more migraine attacks in a lifetime lasting between 4
to 72 hours (whether untreated or unsuccessfully treated).
The attacks needed at least 2 of the following characteristics:
unilateral location, pulsating quality, moderate or severe
pain intensity, and aggravation by or causing avoidance
of routine physical activity. During the attack, patients
must have experienced at least 1 of the following: nausea
and/or vomiting or photophobia and/or phonophobia and
the headache could not be attributed to another disorder
[6]. The control group included friends or spouses of the
probands who did not meet ODYSA questionnaire criteria
for CVS or migraine. We selected those control subjects in
our database who were closest in age to the CVS subjects.
The CVS and migraine subjects included any probands,
family members or control subjects who met the ODYSA-
based criteria for migraine or CVS.
Within the 3 groups we examined the following comor-
bidities: orthostatic intolerance, ﬁbromyalgia, irritable bowel
syndrome, complex regional pain syndrome, functional
dyspepsia, syncope, and interstitial cystitis. Table 1 shows the
source of the adapted inclusion criteria for these comorbid
disorders. Chi-square and Fisher exact tests were used to
compare the 3 categories and student’s t-test was employed
for continuous variables.
5. Results
A total of 103 subjects were included: 21 patients with CVS
(3 children), of whom 7 were in the “milder CVS” group, 46
patients with migraine (3 children), and 36 healthy controls.
In the CVS group, 15 subjects were probands (71%), 5
family members (24%) and 1 friend of a proband (5%).
In the migraine group, 12 were probands (26%), 27 were
family members (59%) and 7 friends of probands (15%).
Female gender was predominant in each group [CVS (86%),
migraine (85%), and healthy controls (64%)]. The mean age
for those with CVS was similar to those with migraine, with
am e a na g eo f4 1± 19.8 (range 6–68) for CVS and a mean
age of 38.6±14.1 (range 12–67) for the migraine group (P =
.06). Healthy controls were about a decade younger with a
mean age of 22.6 ± 13.9 (range 8–55). Table 2 summarizes
the comorbidities present in each group. CVS and migraine
subjects had similar comorbidities including ﬁbromyalgia4 Gastroenterology Research and Practice
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Figure 1:Therangeofautonomicco-morbiditiesincyclicvomiting
syndrome, migraine and healthy control groups.
(38% in CVS and 22% in migraine; P = .12) and orthostatic
intolerance (47% in CVS and 39% in migraine; P = .51).
There was no diﬀerence in the rate of functional dyspepsia in
the 2 groups (9.5% in CVS and 8.7% in migraine). Complex
regional pain syndrome was more commonly reported in
CVS than in migraine group, 23.8% versus 2.2%; P = .01.
More predominant autonomic comorbidities including
orthostatic intolerance, ﬁbromyalgia, and complex regional
painsyndromewerefoundintheCVSgroupwhencompared
to the control subjects. None of the controls had functional
dyspepsia. The proportions of the coexisting autonomic
comorbidities in the 3 groups are shown in Figure 1.
6. Discussion
Our study of CVS in a primarily adult population demon-
strates three key points. First, adult CVS is clearly associated
with other dysautonomias such as orthostatic intolerance,
ﬁbromyalgia, and complex regional pain. This associa-
tion was limited to certain dysautonomias, and was not
observed with others. For example, the rate of irritable
bowel syndrome was not higher in CVS than in controls.
These selective associations may ultimately provide clues
to the pathogenesis of these disorders by demonstrating
links between the disorders that share pathophysiologic
elements and the disorders that do not. For instance, since
CVS appears to be linked with orthostatic intolerance, the
autonomic dysfunction known to play a role in orthostatic
intolerance may also participate in the pathogenesis of
CVS. Second, while signiﬁcant similarities in comorbid
disorders such as orthostatic intolerance, syncope, and
functional dyspepsia clearly bridge CVS and migraine, other
comorbidities are diﬀerent. IBS, which was not associated
with CVS, did demonstrate the expected association with
migraine [9, 22]. IBS occurred in 18/46 (39%) subjects with
migraines, compared to 5/36 control subjects (14%) (P =
.004). The opposite ﬁnding was observed with CRPS which
was more frequent in CVS than in migraineurs, as reported
by others [23]. Taken together, this information supports
a relationship between CVS and migraine but not as close
as one might expect, at least in adults, if one disorder is truly
justavariantoftheother.Third,thesigniﬁcantassociationof
both migraine and CVS with orthostatic intolerance suggests
that these disorders could in fact respond to treatment
directed at improving orthostatic tolerance as previously
reported for other functional gastrointestinal disorders [24,
25]. This last hypothesis will require further evaluation.
The association of migraine with syncope has been
previously highlighted in the CAMERA study, where syn-
cope was more prominent in adults with migraine than
in controls (46% versus 31% in controls) [10]. We have
previously described the association of CVS with postural
tachycardia syndrome and syncope [26] but this study was
limited by referral bias. Patients had been enrolled from an
autonomic laboratory, and their selection for referral for
autonomic testing presumably reﬂected the predominance
of their autonomic symptoms in the ﬁrst place. In contrast,
subjects in this study reﬂected a wide variety of referral
sources, including nonspecialized clinics, the autonomic
laboratory as well as family members of patients seen at
the diﬀerent institutions and friends. The high prevalence
of orthostatic intolerance in the present study can therefore
no longer be attributed to referral bias. The fact that this
high prevalence was seen in both CVS and migraine is
not surprising since it is also seen in other members of
this group of disorders such as ﬁbromyalgia [27], chronic
fatigue [28], and irritable bowel [29]. Perhaps orthostatic
intolerance constitutes the signature ﬁnding across all of
these disorders, reﬂecting a common alteration in central
autonomic network connectivity.
This report is the ﬁrst to report the association of CVS
withﬁbromyalgia.Thisisnotsurprisingaspainisacommon
denominator in children with functional gastrointestinal
disorders and adults with chronic generalized pain. The co-
occurrence of ﬁbromyalgia and functional gastrointestinal
disorders is recognized [29]. Therefore, the association of
ﬁbromyalgia with CVS, which is also a functional gas-
trointestinal disorder, ﬁts with the current understanding
of these disorders. It is striking that the two strongest
associations of CVS, besides orthostatic intolerance, were
both primarily chronic pain syndromes: ﬁbromyalgia and
CRPS.AlthoughthediﬀerencebetweenCVSandmigrainein
theirassociationswithCRPScouldreﬂectoursmallnumbers
(i.e., a type II error), this seems unlikely since the association
occurred in the smaller CVS group where it has previously
been reported, and did not occur in the larger migraine
group. One would expect the opposite in a type II error,
with the ﬁnding occurring in the larger group, and not in the
smaller group where numbers are lacking. The association of
CVS with chronic pain disorders might lead one to consider
whether CVS itself might actually be better classiﬁed as a
member of the group of chronic pain disorders, and whether
the experience of nausea in this context may in fact be a
variant of pain. Since the teleological purpose of nausea
would presumably address some types of food poisoning, a
form of tissue damage, the current International Association
for the Study of Pain deﬁnition of pain would potentially
include nausea: “An unpleasant sensory and emotionalGastroenterology Research and Practice 5
Table 2: Autonomic co-morbidities in Cyclic Vomiting Syndrome (CVS), migraine, and healthy controls.
CVS n = 21 Migraine
n = 46
P value CVS
versus migraine
Control
n = 36
P value CVS
versus controls
Females n (%) 18 (85.7) 39 (84.8) .920 23 (63.9) .08
Age mean ± SD 40.9 ±19.8 38.6 ±14.1 .058 22.64 ±13.9 .077
Orthostatic intolerance n (%) 10 (47.6) 18 (39.1) .51 2 (5.6) .0002
Syncope n (%) 2 (9.5) 4 (8.7) .91 0 (0) .06
Functional dyspepsia 2 (9.5) 4 (8.7) .88 0 (0) .05
Irritable bowel syndrome n (%) 5 (23.8) 18 (39.1) .22 5 (13.9) .34
Migraine n (%) 11 (52.4) 46 (100) — 0 (0) —
Fibromyalgia n (%) 8 (38.1) 10 (21.7) .12 2 (5.6) .0015
Chronic fatigue syndrome n (%) 0 (0) 2 (4.3) .34 2 (5.6) —
Complex regional pain syndrome n (%) 5 (23.8) 1 (2.2) .01 0 (0) —
Interstitial cystitis 1 (4.8) 0( 0 ) N o tr u n 0( 0 ) N o tr u n
experience associated with actual or potential tissue damage,
or described in terms of such damage.” Such a reconcep-
tualization might suggest a more aggressive management
approach, at least in adults, along the lines of a chronic pain
syndrome.
The current therapeutic recommendations for pediatric
CVS in children older than 5 years of age include tricyclic
antidepressants such as amitriptyline [13]. However, these
agents may potentiate orthostatic intolerance due to their
vasodilatory eﬀect. Our results may provide additional
guidance in the management strategy given such a high
prevalence of orthostatic intolerance. Treatment aimed at
orthostatic intolerance such as salt supplementation, ﬂudro-
cortisones, or beta-adrenergic blockers should be clinically
considered and further evaluated as therapy for CVS, both
on their own strength and in combination with other agents
suchastherecommendedtricyclicgroup.Itshouldbekeptin
mind that these recommendations were aimed at a pediatric
population, while the present study included predominantly
adults.
Our study has several limitations. First, we utilized
a questionnaire to ascertain diagnoses. Although these
question sets were based on speciﬁc criteria, the deﬁnitive
diagnosis was not clinically determined through corrobo-
ration by physical examination or laboratory studies where
appropriate. Second, autonomic studies were not performed
on every patient in our study, and the sample of subjects
tested is a partial subgroup of the total. Third, the control
groupwasslightlyyoungerthanthemigraineorCVSgroups,
though this is unlikely to aﬀect the comorbidity ﬁndings,
since CVS and migraine are disorders that tend to aﬀect
younger populations in general. However, we do not know
whether adult CVS is the same disorder as childhood CVS,
and the ﬁndings of this study may or may not apply to the
pediatric population.
We conclude that while CVS and migraine share some
autonomic comorbidities such as orthostatic intolerance,
there are suﬃcient diﬀerences, at least in adults, to question
the traditional teaching that CVS is a variant of migraine. In
addition, the striking association of CVS with pain disorders
such as CRPS and ﬁbromyalgia suggests that it may share
common pathogenic elements with these disorders.
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